Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis”

1,029 trials

Showing 20 of 1,029 results

Large-scale testing (Phase 3)Study completedNCT04167462
What this trial is testing

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea

Who this might be right for
Psoriasis
Bristol-Myers Squibb 220
Not applicableStudy completedNCT02752672
What this trial is testing

Study on the Therapeutic Mechanisms of Dithranol Treatment in Patients With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Medical University of Graz 27
Large-scale testing (Phase 3)Study completedNCT03168256
What this trial is testing

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 528
Large-scale testing (Phase 3)Study completedNCT02905331
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 78
Testing effectiveness (Phase 2)Study completedNCT03630939
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis

Who this might be right for
Psoriatic Plaque
Escalier Biosciences B.V. 104
Large-scale testing (Phase 3)Study completedNCT00258713
What this trial is testing

A 36-Week Extension to Protocol ISA04-03

Who this might be right for
Psoriasis
Aurinia Pharmaceuticals Inc. 309
Early research (Phase 1)Study completedNCT03645499
What this trial is testing

An Open-Label Study to Assess Safety

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 88
Testing effectiveness (Phase 2)UnknownNCT03941431
What this trial is testing

Sequential Treatment of Psoriasis With Integrated Traditional Chinese and Western Medicine

Who this might be right for
Plaque Psoriasis
Shanghai Yueyang Integrated Medicine Hospital 378
Large-scale testing (Phase 3)Study completedNCT01597245
What this trial is testing

Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,224
Testing effectiveness (Phase 2)Study completedNCT00770965
What this trial is testing

Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 80
Not applicableLooking for participantsNCT06029257
What this trial is testing

Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)

Who this might be right for
Genital Psoriasis
Almirall, S.A. 110
Testing effectiveness (Phase 2)Study completedNCT03850483
What this trial is testing

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

Who this might be right for
Psoriasis
Pfizer 344
Not applicableStudy completedNCT01202565
What this trial is testing

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 506
Testing effectiveness (Phase 2)Study completedNCT03832738
What this trial is testing

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasisSkin Diseases
Akros Pharma Inc. 152
Testing effectiveness (Phase 2)Study completedNCT00755196
What this trial is testing

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Who this might be right for
Psoriasis
Pfizer 30
Early research (Phase 1)UnknownNCT06396013
What this trial is testing

A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.

Who this might be right for
Plaque Psoriasis
Beijing Hospital of Traditional Chinese Medicine 96
Testing effectiveness (Phase 2)Study completedNCT04629950
What this trial is testing

Rimegepant in Moderate Plaque-type Psoriasis

Who this might be right for
Psoriasis
Weill Medical College of Cornell University 41
Large-scale testing (Phase 3)UnknownNCT06299982
What this trial is testing

An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO

Who this might be right for
Plaque Psoriasis Patients
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 750
Large-scale testing (Phase 3)Study completedNCT02471144
What this trial is testing

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Who this might be right for
Chronic Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 162
Testing effectiveness (Phase 2)Ended earlyNCT03339999
What this trial is testing

AGN-242428 in the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Vitae Pharmaceuticals, Inc. 24
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation